Compare UBER & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UBER | PRME |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.5B | 601.1M |
| IPO Year | 2019 | 2022 |
| Metric | UBER | PRME |
|---|---|---|
| Price | $79.05 | $3.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 35 | 5 |
| Target Price | ★ $108.75 | $6.42 |
| AVG Volume (30 Days) | ★ 22.2M | 3.8M |
| Earning Date | 02-04-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 286.11 | N/A |
| EPS | ★ 7.80 | N/A |
| Revenue | ★ $49,610,000,000.00 | $5,977,000.00 |
| Revenue This Year | $20.62 | $111.80 |
| Revenue Next Year | $15.85 | N/A |
| P/E Ratio | $10.17 | ★ N/A |
| Revenue Growth | 18.25 | ★ 647.13 |
| 52 Week Low | $59.75 | $1.11 |
| 52 Week High | $101.99 | $6.94 |
| Indicator | UBER | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 31.07 | 43.10 |
| Support Level | $78.78 | $3.59 |
| Resistance Level | $86.45 | $4.12 |
| Average True Range (ATR) | 2.44 | 0.34 |
| MACD | -0.77 | 0.00 |
| Stochastic Oscillator | 4.98 | 33.62 |
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing (eVTOL) technology. Uber operates in over 70 countries, with over 180 million users who order rides or food at least once a month.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.